Hong Kong Training Portal on
Infection Control and Infectious Disease

FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis

Ebola outbreak in the Democratic Republic of the Congo declared a Public Health Emergency of International Concern

Reporting of Candida auris, Centre for Health Protection. Letter to Hospital

First FDA-approved vaccine for the prevention of dengue disease in endemic regions

World Immunization Week

Measles cases rose nearly four-fold in first quarter 2019: WHO

Update on the Situation of Measles and the Recommended Schedule of Measles-containing Vaccine in Childhood Immunisation Programm

Scientific recommendations on pertussis vaccination for pregnant women in Hong Kong

Educational video on Control of MDROs in Hong Kong

Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics

Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea

FDA approves new drug to treat influenza

A Step Forward in the Treatment of Influenza

CHP investigates local cases of dengue fever

CHP notified of human case of avian influenza A (H7N4) in Mainland

Use of neuraminidase inhibitors in out-patient settings

Plague outbreak external situation reports 1 – 14 (WHO Africa)

CHP launches Antibiotic Stewardship Programme in Primary Care and updated IMPACT guidelines

Government embarks to provide PCV13 to eligible elderly persons in 2017/18

Medical Device Safety Alert: FDA Bans Powdered Surgeon's Gloves, Powdered Patient Examination Gloves, and Absorbable Powder for Lubricating a Surgeon's Glove